Edition:
United Kingdom

Marksans Pharma Ltd (MARK.NS)

MARK.NS on National Stock Exchange of India

22.45INR
20 Feb 2019
Change (% chg)

-- (--)
Prev Close
Rs22.45
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,273,799
52-wk High
Rs40.60
52-wk Low
Rs21.95

Latest Key Developments (Source: Significant Developments)

Marksans Pharma Says UK MHRA Grants Marketing Authorisation For Loratadine Oral Solution
Tuesday, 5 Feb 2019 

Feb 5 (Reuters) - Marksans Pharma Ltd ::ANNOUNCES UK MHRA GRANT OF MARKETING AUTHORISATION FOR LORATADINE 5MG/5ML ORAL SOLUTION.SAYS PRODUCT WILL BE MANUFACTURED IN ITS UK FACILITY.  Full Article

India's Marksans Pharma Sept-Qtr Consol Profit Rises
Tuesday, 13 Nov 2018 

Nov 13 (Reuters) - Marksans Pharma Ltd ::SEPT QUARTER CONSOL PROFIT 205.7 MILLION RUPEES VERSUS PROFIT 104.1 MILLION RUPEES YEAR AGO.SEPT QUARTER CONSOL REVENUE FROM OPERATIONS 2.69 BILLION RUPEES VERSUS 2.74 BILLION RUPEES YEAR AGO.  Full Article

India's Marksans Pharma Posts March-Qtr Profit
Wednesday, 30 May 2018 

May 30 (Reuters) - Marksans Pharma Ltd ::MARCH QUARTER PROFIT 43.3 MILLION RUPEES VERSUS LOSS 24.4 MILLION RUPEES YEAR AGO.MARCH QUARTER REVENUE FROM OPERATIONS 868.4 MILLION RUPEES VERSUS 539.5 MILLION RUPEES YEAR AGO.  Full Article

India's Marksans Pharma Sept-qtr consol profit rises
Monday, 13 Nov 2017 

Nov 13 (Reuters) - Marksans Pharma Ltd ::Sept quarter consol profit 104.1 million rupees versus profit of 7.5 million rupees year ago.Sept quarter consol revenue from operations 2.74 billion rupees versus 1.80 billion rupees year ago.  Full Article